Trial Profile
A Clinical Study to Investigate Pharmacokinetics and Safety of Single-Dose TRK-820 Soft Capsule in Patient With Hemodialysis
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 14 Jan 2020
Price :
$35
*
At a glance
- Drugs Nalfurafine (Primary)
- Indications Pruritus
- Focus Adverse reactions; Pharmacokinetics
- Acronyms TRK-820
- Sponsors SK Chemicals
- 06 Dec 2010 New trial record